| Dr Joseph H Mehring, DC | |
|
1575 N Rivercenter Dr, Milwaukee, WI 53212-3978 | |
| (414) 283-8444 | |
| Not Available |
| Full Name | Dr Joseph H Mehring |
|---|---|
| Gender | Male |
| Speciality | Chiropractic |
| Experience | 13 Years |
| Location | 1575 N Rivercenter Dr, Milwaukee, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104198605 | NPI | - | NPPES |
| 100021539 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 4857-12 (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aurora Medical Group, Inc. | 6709794258 | 3207 |
News Archive
The research on the short and long-term effects of COVID-19 disease is ongoing. Still, scientists have found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects the brain causing loss of smell and taste, dizziness, muscle pain, fatigue, and other cognitive impairments. However, it remained unknown why certain people developed neurological symptoms while others did not.
Cyntellect, Inc., a privately-held life sciences company commercializing products to advance life science and stem cell research, biopharmaceutical production, and drug discovery, today unveiled its Celigo™ adherent cell cytometry system, the Company's new platform for non-invasive in situ live cell imaging.
Kumar Sharma, MD, FAHA, professor of medicine at the University of California, San Diego School of Medicine and director of the Center for Renal Translational Medicine, has received a $5.9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health, to study kidney complications related to type 1 and type 2 diabetes.
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the release of Volocity® 6.0, the latest version of the Company's 3D cellular imaging software.
Adding more good news to last week's announcement that Nexavar (sorafenib) may be the first effective treatment for advanced liver cancer, researchers at the Lombardi Comprehensive Cancer Center at Georgetown University have uncovered a new molecular mechanism that may 'spontaneously' cause liver cancer.
› Verified 6 days ago
| Provider Name | Aurora Medical Group, Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1427271378 PECOS PAC ID: 6709794258 Enrollment ID: O20031105000725 |
News Archive
The research on the short and long-term effects of COVID-19 disease is ongoing. Still, scientists have found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects the brain causing loss of smell and taste, dizziness, muscle pain, fatigue, and other cognitive impairments. However, it remained unknown why certain people developed neurological symptoms while others did not.
Cyntellect, Inc., a privately-held life sciences company commercializing products to advance life science and stem cell research, biopharmaceutical production, and drug discovery, today unveiled its Celigo™ adherent cell cytometry system, the Company's new platform for non-invasive in situ live cell imaging.
Kumar Sharma, MD, FAHA, professor of medicine at the University of California, San Diego School of Medicine and director of the Center for Renal Translational Medicine, has received a $5.9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health, to study kidney complications related to type 1 and type 2 diabetes.
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the release of Volocity® 6.0, the latest version of the Company's 3D cellular imaging software.
Adding more good news to last week's announcement that Nexavar (sorafenib) may be the first effective treatment for advanced liver cancer, researchers at the Lombardi Comprehensive Cancer Center at Georgetown University have uncovered a new molecular mechanism that may 'spontaneously' cause liver cancer.
› Verified 6 days ago
| Provider Name | Lakeshore Medical Clinic Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1003861188 PECOS PAC ID: 7719890730 Enrollment ID: O20031106000481 |
News Archive
The research on the short and long-term effects of COVID-19 disease is ongoing. Still, scientists have found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects the brain causing loss of smell and taste, dizziness, muscle pain, fatigue, and other cognitive impairments. However, it remained unknown why certain people developed neurological symptoms while others did not.
Cyntellect, Inc., a privately-held life sciences company commercializing products to advance life science and stem cell research, biopharmaceutical production, and drug discovery, today unveiled its Celigo™ adherent cell cytometry system, the Company's new platform for non-invasive in situ live cell imaging.
Kumar Sharma, MD, FAHA, professor of medicine at the University of California, San Diego School of Medicine and director of the Center for Renal Translational Medicine, has received a $5.9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health, to study kidney complications related to type 1 and type 2 diabetes.
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the release of Volocity® 6.0, the latest version of the Company's 3D cellular imaging software.
Adding more good news to last week's announcement that Nexavar (sorafenib) may be the first effective treatment for advanced liver cancer, researchers at the Lombardi Comprehensive Cancer Center at Georgetown University have uncovered a new molecular mechanism that may 'spontaneously' cause liver cancer.
› Verified 6 days ago
| Provider Name | Aurora Health Care Metro Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1861447179 PECOS PAC ID: 8628986536 Enrollment ID: O20040114000498 |
News Archive
The research on the short and long-term effects of COVID-19 disease is ongoing. Still, scientists have found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects the brain causing loss of smell and taste, dizziness, muscle pain, fatigue, and other cognitive impairments. However, it remained unknown why certain people developed neurological symptoms while others did not.
Cyntellect, Inc., a privately-held life sciences company commercializing products to advance life science and stem cell research, biopharmaceutical production, and drug discovery, today unveiled its Celigo™ adherent cell cytometry system, the Company's new platform for non-invasive in situ live cell imaging.
Kumar Sharma, MD, FAHA, professor of medicine at the University of California, San Diego School of Medicine and director of the Center for Renal Translational Medicine, has received a $5.9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health, to study kidney complications related to type 1 and type 2 diabetes.
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the release of Volocity® 6.0, the latest version of the Company's 3D cellular imaging software.
Adding more good news to last week's announcement that Nexavar (sorafenib) may be the first effective treatment for advanced liver cancer, researchers at the Lombardi Comprehensive Cancer Center at Georgetown University have uncovered a new molecular mechanism that may 'spontaneously' cause liver cancer.
› Verified 6 days ago
| Provider Name | Aurora Advanced Healthcare Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1265629133 PECOS PAC ID: 3375625833 Enrollment ID: O20080123000694 |
News Archive
The research on the short and long-term effects of COVID-19 disease is ongoing. Still, scientists have found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects the brain causing loss of smell and taste, dizziness, muscle pain, fatigue, and other cognitive impairments. However, it remained unknown why certain people developed neurological symptoms while others did not.
Cyntellect, Inc., a privately-held life sciences company commercializing products to advance life science and stem cell research, biopharmaceutical production, and drug discovery, today unveiled its Celigo™ adherent cell cytometry system, the Company's new platform for non-invasive in situ live cell imaging.
Kumar Sharma, MD, FAHA, professor of medicine at the University of California, San Diego School of Medicine and director of the Center for Renal Translational Medicine, has received a $5.9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health, to study kidney complications related to type 1 and type 2 diabetes.
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the release of Volocity® 6.0, the latest version of the Company's 3D cellular imaging software.
Adding more good news to last week's announcement that Nexavar (sorafenib) may be the first effective treatment for advanced liver cancer, researchers at the Lombardi Comprehensive Cancer Center at Georgetown University have uncovered a new molecular mechanism that may 'spontaneously' cause liver cancer.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph H Mehring, DC 1575 N Rivercenter Dr, Milwaukee, WI 53212-3978 Ph: (414) 283-8444 | Dr Joseph H Mehring, DC 1575 N Rivercenter Dr, Milwaukee, WI 53212-3978 Ph: (414) 283-8444 |
News Archive
The research on the short and long-term effects of COVID-19 disease is ongoing. Still, scientists have found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects the brain causing loss of smell and taste, dizziness, muscle pain, fatigue, and other cognitive impairments. However, it remained unknown why certain people developed neurological symptoms while others did not.
Cyntellect, Inc., a privately-held life sciences company commercializing products to advance life science and stem cell research, biopharmaceutical production, and drug discovery, today unveiled its Celigo™ adherent cell cytometry system, the Company's new platform for non-invasive in situ live cell imaging.
Kumar Sharma, MD, FAHA, professor of medicine at the University of California, San Diego School of Medicine and director of the Center for Renal Translational Medicine, has received a $5.9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health, to study kidney complications related to type 1 and type 2 diabetes.
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the release of Volocity® 6.0, the latest version of the Company's 3D cellular imaging software.
Adding more good news to last week's announcement that Nexavar (sorafenib) may be the first effective treatment for advanced liver cancer, researchers at the Lombardi Comprehensive Cancer Center at Georgetown University have uncovered a new molecular mechanism that may 'spontaneously' cause liver cancer.
› Verified 6 days ago
Dr. Adebayo Yusuf, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 5542 W Fond Du Lac Ave, Milwaukee, WI 53216 Phone: 414-461-2222 Fax: 414-461-8289 | |
Dr. Spencer Michael Kronz, DC Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 1726 E North Ave, Milwaukee, WI 53202 Phone: 608-219-5176 | |
Advanced Health And Wellness Medical Center, Sc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 3113 S 13th St, Milwaukee, WI 53215 Phone: 414-643-6000 Fax: 414-643-1352 | |
Dr. Elizabeth Ann Merriman, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 140 S 1st St Ste 101, Milwaukee, WI 53204 Phone: 414-271-1717 | |
Chiropractic Company - Milwaukee Downtown Ltd Chiropractor Medicare: Medicare Enrolled Practice Location: 270 E Highland Ave Ste A, Milwaukee, WI 53202 Phone: 414-220-9441 | |
Kevin Mark Servi, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 3975 N 68th St, #204, Milwaukee, WI 53216 Phone: 414-616-9999 Fax: 414-616-7777 | |
Dr. Brandy R Ferrara, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1661 N Water St, Suite 207, Milwaukee, WI 53202 Phone: 414-430-3211 |